InvestorsHub Logo
Followers 58
Posts 10057
Boards Moderated 1
Alias Born 09/21/2016

Re: Steady_T post# 357128

Tuesday, 04/12/2022 4:34:42 PM

Tuesday, April 12, 2022 4:34:42 PM

Post# of 458908
Steady_T

That doesn't look like MIssling want to continue being the infamous "One man show" we keep hearing about.



Yup, he has taken a few jabs on style but now we see he needed to get results so he could do a little structural stuff. He had a good plan but stealth (opposite of running your mouth...see BIIB) had to be part of it while he built trial data and formed a process sequence w/understanding/validating the MOA/thesis by /execution - w/results.(see RSD) I understand others might assess it differently but , it is what it is.

IMO, we are witnessing the creation phase based on BIOMED 101. Avxl are acting like they have what is needed and that they have structural plans to work out while trial information is complied and completed w/low vis-regulatory interaction up next. We observe they are not acting like they are in doubt about the future.

IMO, we may hear positive stealth words from a third party as a process gets worked which are intended to make everyone (who needs to reassured) that proper and adequate technical control has been executed with multiple levels of regulatory detail.

News might come from anywhere as we lead up to FDA(other bodies) news. I am guessing such news will seem (Oh BTW) but it is all part of the plan to build a little credibility for talks w/FDA staff , who must be nervous B/C they have shot themselves so many times in the foot.

We'll see...all just guessing but this ain't our first rodeo. All the best to longs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News